CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 276 entries

View as:

Cooperative Re-Engagement Controlled Trial (CoRECT)

Phase: N/A Priority: Normal

NCT ID: NCT02693145 Org: User:

Start: 08/31/16 End: 08/31/20 Due: 08/31/21

Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules

Phase: N/A Priority: Normal

NCT ID: NCT02412514 Org: User:

Start: 04/30/15 End: 12/31/15 Due: 12/31/16

Dane County Safety Assessment (SAFE) Research Study

Phase: N/A Priority: Normal

NCT ID: NCT00140322 Org: User:

Start: 10/31/02 End: 08/31/05 Due: 08/31/06

Behavioral Counseling Intervention Trial to Reduce Alcohol-related Sexual Risk Behavior Among HIV-negative Men in Namibia

Phase: N/A Priority: Normal

NCT ID: NCT02359487 Org: User:

Start: 02/28/11 End: 04/30/13 Due: 04/30/14

HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings

Phase: N/A Priority: Normal

NCT ID: NCT01256463 Org: User:

Start: 10/31/09 End: 01/31/13 Due: 01/31/14

Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine

Phase: N/A Priority: Normal

NCT ID: NCT00137696 Org: User:

Start: 07/31/03 End: 07/31/04 Due: 07/31/05

Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi

Phase: N/A Priority: Normal

NCT ID: NCT00164359 Org: User:

Start: 04/30/05 End: 09/30/05 Due: 09/30/06

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Phase: N/A Priority: Normal

NCT ID: NCT00023387 Org: User:

Start: 03/31/00 End: 05/31/01 Due: 05/31/02

Partner Notification Intervention for STD Clinics.

Phase: N/A Priority: Normal

NCT ID: NCT00207571 Org: User:

Start: 04/30/01 End: 10/31/05 Due: 10/31/06

Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil

Phase: N/A Priority: Normal

NCT ID: NCT02600767 Org: User:

Start: 12/31/15 End: 12/31/16 Due: 12/31/17

HIP: HIV Intervention for Providers

Phase: N/A Priority: Normal

NCT ID: NCT00164398 Org: User:

Start: 06/30/04 End: 09/30/08 Due: 09/30/09

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Phase: N/A Priority: Normal

NCT ID: NCT01538940 Org: User:

Start: 11/01/11 End: 10/31/15 Due: 10/31/16

Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS

Phase: N/A Priority: Normal

NCT ID: NCT00267436 Org: User:

Start: 07/31/06 End: 02/28/07 Due: 02/28/08

Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV

Phase: N/A Priority: Normal

NCT ID: NCT06045923 Org: User:

Start: 03/17/23 End: 10/01/26 Due: 10/01/27

Project TEAM: Teaching HIV Prevention in the HIV Clinic

Phase: N/A Priority: Normal

NCT ID: NCT00164320 Org: User:

Start: 05/31/04 End: 05/31/06 Due: 05/31/07

Ethiopia Antimalarial in Vivo Efficacy Study 2012

Phase: N/A Priority: Normal

NCT ID: NCT01680406 Org: User:

Start: 10/31/12 End: 12/31/14 Due: 12/31/15

Evaluation of the Active Living Every Day Exercise Program for People With Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00146367 Org: User:

Start: 01/31/04 End: 10/31/05 Due: 10/31/06

Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand

Phase: N/A Priority: Normal

NCT ID: NCT02073240 Org: User:

Start: 02/17/14 End: 11/18/16 Due: 11/18/17

Efficacy of Flow Restrictors in Limiting Access of Liquid Medicines by Young Children

Phase: N/A Priority: Normal

NCT ID: NCT06938620 Org: User:

Start: 04/30/12 End: 05/31/12 Due: 05/31/13

Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

Phase: N/A Priority: Normal

NCT ID: NCT00448981 Org: User:

Start: 11/30/06 End: 06/30/08 Due: 06/30/09

Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR

Phase: N/A Priority: Normal

NCT ID: NCT00164619 Org: User:

Start: 07/31/01 End: 03/31/08 Due: 03/31/09

HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed Intervention

Phase: N/A Priority: Normal

NCT ID: NCT03465852 Org: User:

Start: 07/15/19 End: 09/30/22 Due: 09/30/23

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

Phase: N/A Priority: Normal

NCT ID: NCT03725618 Org: User:

Start: 11/01/18 End: 09/01/21 Due: 09/01/22

A Comparison of the ASHC and CDSMP

Phase: N/A Priority: Normal

NCT ID: NCT00207415 Org: User:

Start: 01/31/03 End: 12/31/04 Due: 12/31/05

ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader

Phase: N/A Priority: Normal

NCT ID: NCT00252109 Org: User:

Start: 07/31/04 End: 01/31/09 Due: 01/31/10

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Cooperative Re-Engagement Controlled Trial (CoRECT)	NCT02693145	Centers for Disease Control and Prevention	user2@example.com	None	2016-08-31	2020-08-31	2021-08-31	-	-	2025-07-14
Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules	NCT02412514	Centers for Disease Control and Prevention	user2@example.com	None	2015-04-30	2015-12-31	2016-12-31	-	-	2025-07-14
Dane County Safety Assessment (SAFE) Research Study	NCT00140322	Centers for Disease Control and Prevention	user2@example.com	None	2002-10-31	2005-08-31	2006-08-31	-	-	2025-07-14
Behavioral Counseling Intervention Trial to Reduce Alcohol-related Sexual Risk Behavior Among HIV-negative Men in Namibia	NCT02359487	Centers for Disease Control and Prevention	user2@example.com	None	2011-02-28	2013-04-30	2014-04-30	-	-	2025-07-14
HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings	NCT01256463	Centers for Disease Control and Prevention	user2@example.com	None	2009-10-31	2013-01-31	2014-01-31	-	-	2025-07-14
Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine	NCT00137696	Centers for Disease Control and Prevention	user2@example.com	None	2003-07-31	2004-07-31	2005-07-31	-	-	2025-07-14
Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi	NCT00164359	Centers for Disease Control and Prevention	user2@example.com	None	2005-04-30	2005-09-30	2006-09-30	-	-	2025-07-14
TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine	NCT00023387	Centers for Disease Control and Prevention	user2@example.com	None	2000-03-31	2001-05-31	2002-05-31	-	-	2025-07-14
Partner Notification Intervention for STD Clinics.	NCT00207571	Centers for Disease Control and Prevention	user2@example.com	None	2001-04-30	2005-10-31	2006-10-31	-	-	2025-07-14
Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil	NCT02600767	Centers for Disease Control and Prevention	user2@example.com	None	2015-12-31	2016-12-31	2017-12-31	-	-	2025-07-14
HIP: HIV Intervention for Providers	NCT00164398	Centers for Disease Control and Prevention	user2@example.com	None	2004-06-30	2008-09-30	2009-09-30	-	-	2025-07-14
Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand	NCT01538940	Centers for Disease Control and Prevention	user2@example.com	None	2011-11-01	2015-10-31	2016-10-31	-	-	2025-07-14
Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS	NCT00267436	Centers for Disease Control and Prevention	user2@example.com	None	2006-07-31	2007-02-28	2008-02-28	-	-	2025-07-14
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV	NCT06045923	Centers for Disease Control and Prevention	user2@example.com	None	2023-03-17	2026-10-01	2027-10-01	-	-	2025-07-14
Project TEAM: Teaching HIV Prevention in the HIV Clinic	NCT00164320	Centers for Disease Control and Prevention	user2@example.com	None	2004-05-31	2006-05-31	2007-05-31	-	-	2025-07-14
Ethiopia Antimalarial in Vivo Efficacy Study 2012	NCT01680406	Centers for Disease Control and Prevention	user2@example.com	None	2012-10-31	2014-12-31	2015-12-31	-	-	2025-07-14
Evaluation of the Active Living Every Day Exercise Program for People With Arthritis	NCT00146367	Centers for Disease Control and Prevention	user2@example.com	None	2004-01-31	2005-10-31	2006-10-31	-	-	2025-07-14
Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand	NCT02073240	Centers for Disease Control and Prevention	user2@example.com	None	2014-02-17	2016-11-18	2017-11-18	-	-	2025-07-14
Efficacy of Flow Restrictors in Limiting Access of Liquid Medicines by Young Children	NCT06938620	Centers for Disease Control and Prevention	user2@example.com	None	2012-04-30	2012-05-31	2013-05-31	-	-	2025-07-14
Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial	NCT00448981	Centers for Disease Control and Prevention	user2@example.com	None	2006-11-30	2008-06-30	2009-06-30	-	-	2025-07-14
Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR	NCT00164619	Centers for Disease Control and Prevention	user2@example.com	None	2001-07-31	2008-03-31	2009-03-31	-	-	2025-07-14
HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed Intervention	NCT03465852	Centers for Disease Control and Prevention	user2@example.com	None	2019-07-15	2022-09-30	2023-09-30	-	-	2025-07-14
Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old	NCT03725618	Centers for Disease Control and Prevention	user2@example.com	None	2018-11-01	2021-09-01	2022-09-01	-	-	2025-07-14
A Comparison of the ASHC and CDSMP	NCT00207415	Centers for Disease Control and Prevention	user2@example.com	None	2003-01-31	2004-12-31	2005-12-31	-	-	2025-07-14
ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader	NCT00252109	Centers for Disease Control and Prevention	user2@example.com	None	2004-07-31	2009-01-31	2010-01-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance